Nabriva Therapeutics AG IPO Info

Company Name: Nabriva Therapeutics AG
Stock Symbol: NBRV
Exchange: NASDAQ
Status: Priced
IPO Date: 9/18/2015
IPO Price: 10.25 (-6.15%)

Underwriters

Leerink Partners, RBC Capital Markets, Needham & Company, Wedbush PacGrow

Amount of Offering: N/A
Number of Shares Offered: 9 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A

Company Description

Nabriva Therapeutics is a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.

SEC Filings

News Headlines

• Nabriva Therapeutics AG (NBRV) IPO Opens Up 8%
• Nabriva Therapeutics AG (NBRV) IPO Prices at $10.25/ADS, Slightly Below Expectations
• IPOs Expected for 9/18: (PEN) (NBRV)
• Nabriva Therapeutics (NBRV) Files $92M IPO